Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy in Treating Pain in Patients With Hormone Refractory Metastatic Prostate Cancer
This study is ongoing, but not recruiting participants.
Study NCT00003232 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pain
Prostate Cancer
Quality of Life
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
clodronate disodium
mitoxantrone hydrochloride
prednisone
quality-of-life assessment
Additional drug interventions recognized in this trial
Clodronic Acid
Mitoxantrone
More general drug interventions related to this trial
Analgesics
Anti-Inflammatory Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Central Nervous System Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
NCIC Clinical Trials Group
Back to top of Main Content
